<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33921446</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>12</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Where and Why Modeling Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3977</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22083977</ELocationID><Abstract><AbstractText>Over the years, researchers have leveraged a host of different in vivo models in order to dissect amyotrophic lateral sclerosis (ALS), a neurodegenerative/neuroinflammatory disease that is heterogeneous in its clinical presentation and is multigenic, multifactorial and non-cell autonomous. These models include both vertebrates and invertebrates such as yeast, worms, flies, zebrafish, mice, rats, guinea pigs, dogs and, more recently, non-human primates. Despite their obvious differences and peculiarities, only the concurrent and comparative analysis of these various systems will allow the untangling of the causes and mechanisms of ALS for finally obtaining new efficacious therapeutics. However, harnessing these powerful organisms poses numerous challenges. In this context, we present here an updated and comprehensive review of how eukaryotic unicellular and multicellular organisms that reproduce a few of the main clinical features of the disease have helped in ALS research to dissect the pathological pathways of the disease insurgence and progression. We describe common features as well as discrepancies among these models, highlighting new insights and emerging roles for experimental organisms in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liguori</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3456-6574</Identifier><AffiliationInfo><Affiliation>Preclinical Neuroscience, IRCCS Santa Lucia Foundation, 00143 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amadio</LastName><ForeName>Susanna</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9266-4597</Identifier><AffiliationInfo><Affiliation>Preclinical Neuroscience, IRCCS Santa Lucia Foundation, 00143 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volont&#xe9;</LastName><ForeName>Cinzia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7362-8307</Identifier><AffiliationInfo><Affiliation>Preclinical Neuroscience, IRCCS Santa Lucia Foundation, 00143 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Systems Analysis and Computer Science "A. Ruberti", National Research Council (IASI-CNR), 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Ricerca Corrente FSL</GrantID><Agency>Ministero della Salute</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030801" MajorTopicYN="N">Animals, Genetically Modified</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017173" MajorTopicYN="N">Caenorhabditis elegans</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006168" MajorTopicYN="N">Guinea Pigs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015027" MajorTopicYN="N">Zebrafish</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Caenorhabditis elegans</Keyword><Keyword MajorTopicYN="N">Danio rerio</Keyword><Keyword MajorTopicYN="N">Drosophila melanogaster</Keyword><Keyword MajorTopicYN="N">Saccharomyces cerevisiae</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">animal modeling</Keyword><Keyword MajorTopicYN="N">canines</Keyword><Keyword MajorTopicYN="N">non-human primates</Keyword><Keyword MajorTopicYN="N">rodents</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33921446</ArticleId><ArticleId IdType="pmc">PMC8070525</ArticleId><ArticleId IdType="doi">10.3390/ijms22083977</ArticleId><ArticleId IdType="pii">ijms22083977</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yerbury J.J., Farrawell N.E., McAlary L. Proteome Homeostasis Dysfunction: A Unifying Principle in ALS Pathogenesis. Trends Neurosci. 2020;43:274&#x2013;284. doi: 10.1016/j.tins.2020.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2020.03.002</ArticleId><ArticleId IdType="pubmed">32353332</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousefian-Jazi A., Seol Y., Kim J., Ryu H.L., Lee J., Ryu H. Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis. Cells. 2020;9:2687. doi: 10.3390/cells9122687.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9122687</ArticleId><ArticleId IdType="pmc">PMC7765192</ArticleId><ArticleId IdType="pubmed">33333804</ArticleId></ArticleIdList></Reference><Reference><Citation>Volont&#xe9; C., Morello G., Spampinato A.G., Amadio S., Apolloni S., D&#x2019;Agata V., Cavallaro S. Omics-based exploration and functional validation of neurotrophic factors and histamine as therapeutic targets in ALS. Ageing Res. Rev. 2020;62:101121. doi: 10.1016/j.arr.2020.101121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2020.101121</ArticleId><ArticleId IdType="pubmed">32653439</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki N., Akiyama T., Warita H., Aoki M. Omics Approach to Axonal Dysfunction of Motor Neurons in Amyotrophic Lateral Sclerosis (ALS) Front. Neurosci. 2020;14:194. doi: 10.3389/fnins.2020.00194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00194</ArticleId><ArticleId IdType="pmc">PMC7109447</ArticleId><ArticleId IdType="pubmed">32269505</ArticleId></ArticleIdList></Reference><Reference><Citation>Gittings L.M., Sattler R. Recent advances in understanding amyotrophic lateral sclerosis and emerging therapies. Fac. Rev. 2020;9:12. doi: 10.12703/b/9-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.12703/b/9-12</ArticleId><ArticleId IdType="pmc">PMC7886072</ArticleId><ArticleId IdType="pubmed">33659944</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G., Gautier O., Tassoni-Tsuchida E., Ma X.R., Gitler A.D. ALS Genetics: Gains, Losses, and Implications for Future Therapies. Neuron. 2020;108:822&#x2013;842. doi: 10.1016/j.neuron.2020.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.08.022</ArticleId><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivandzade F., Cucullo L. Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview. Int. J. Mol. Sci. 2021;22:2153. doi: 10.3390/ijms22042153.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22042153</ArticleId><ArticleId IdType="pmc">PMC7926761</ArticleId><ArticleId IdType="pubmed">33671500</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaricamazza S., Salvatori I., Ferri A., Valle C. Skeletal Muscle in ALS: An Unappreciated Therapeutic Opportunity? Cells. 2021;10:525. doi: 10.3390/cells10030525.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030525</ArticleId><ArticleId IdType="pmc">PMC8000428</ArticleId><ArticleId IdType="pubmed">33801336</ArticleId></ArticleIdList></Reference><Reference><Citation>Volont&#xe9; C., Apolloni S., Sabatelli M. Histamine beyond its effects on allergy: Potential therapeutic benefits for the treatment of Amyotrophic Lateral Sclerosis (ALS) Pharmacol. Ther. 2019;202:120&#x2013;131. doi: 10.1016/j.pharmthera.2019.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2019.06.006</ArticleId><ArticleId IdType="pubmed">31233766</ArticleId></ArticleIdList></Reference><Reference><Citation>Shatunov A., Al-Chalabi A. The genetic architecture of ALS. Neurobiol. Dis. 2021;147:105156. doi: 10.1016/j.nbd.2020.105156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105156</ArticleId><ArticleId IdType="pubmed">33130222</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P.C., Hentati A., Donaldson D.H., Goto J., O&#x2019;Regan J.P., Deng H.-X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P., et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science. 1993;261:1047&#x2013;1051. doi: 10.1126/science.8351519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8351519</ArticleId><ArticleId IdType="pubmed">8351519</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M., Valentine J.S. Aggregation of Copper&#x2013;Zinc Superoxide Dismutase in Familial and Sporadic ALS. Antioxid. Redox Signal. 2009;11:1603&#x2013;1614. doi: 10.1089/ars.2009.2536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2536</ArticleId><ArticleId IdType="pmc">PMC2842589</ArticleId><ArticleId IdType="pubmed">19271992</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15e;ahin A., Held A., Bredvik K., Major P., Achilli T.-M., Kerson A.G., Wharton K., Stilwell G., Reenan R. Human SOD1 ALS Mutations in a Drosophila Knock-In Model Cause Severe Phenotypes and Reveal Dosage-Sensitive Gain- and Loss-of-Function Components. Genetics. 2017;205:707&#x2013;723. doi: 10.1534/genetics.116.190850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.116.190850</ArticleId><ArticleId IdType="pmc">PMC5289846</ArticleId><ArticleId IdType="pubmed">27974499</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., Cleveland D.W. Aggregation and Motor Neuron Toxicity of an ALS-Linked SOD1 Mutant Independent from Wild-Type SOD1. Science. 1998;281:1851&#x2013;1854. doi: 10.1126/science.281.5384.1851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.281.5384.1851</ArticleId><ArticleId IdType="pubmed">9743498</ArticleId></ArticleIdList></Reference><Reference><Citation>Yim M.B., Kang J.H., Yim H.S., Kwak H.S., Chock P.B., Stadtman E.R. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl. Acad. Sci. USA. 1996;93:5709&#x2013;5714. doi: 10.1073/pnas.93.12.5709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.12.5709</ArticleId><ArticleId IdType="pmc">PMC39125</ArticleId><ArticleId IdType="pubmed">8650157</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M., Cleveland D.W. Non&#x2013;cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 2009;187:761&#x2013;772. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Cali&#xf3; M.L., Henriques E., Siena A., Bertoncini C.R.A., Gil-Mohapel J., Rosenstock T.R. Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment. Front. Neurosci. 2020;14:679. doi: 10.3389/fnins.2020.00679.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00679</ArticleId><ArticleId IdType="pmc">PMC7373761</ArticleId><ArticleId IdType="pubmed">32760239</ArticleId></ArticleIdList></Reference><Reference><Citation>Par&#xe9; B., Lehmann M., Beaudin M., Nordstr&#xf6;m U., Saikali S., Julien J.-P., Gilthorpe J.D., Marklund S.L., Cashman N.R., Andersen P.M., et al. Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis. Sci. Rep. 2018;8:1&#x2013;13. doi: 10.1038/s41598-018-31773-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31773-z</ArticleId><ArticleId IdType="pmc">PMC6155098</ArticleId><ArticleId IdType="pubmed">30242181</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Velde C.V., Cleveland D.W. ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors. Neuron. 2006;52:39&#x2013;59. doi: 10.1016/j.neuron.2006.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Boillee S., Roberts E.A., Garcia M.L., McAlonis-Downes M., Mikse O.R., Cleveland D.W., Goldstein L.S.B. Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc. Natl. Acad. Sci. USA. 2008;105:7594&#x2013;7599. doi: 10.1073/pnas.0802556105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0802556105</ArticleId><ArticleId IdType="pmc">PMC2396671</ArticleId><ArticleId IdType="pubmed">18492803</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco D.A., Lemay N., Ko H.K., Zhou H., Burke C., Kwiatkowski T.J., Sapp P., McKenna-Yasek D., Brown R.H., Hayward L.J. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum. Mol. Genet. 2010;19:4160&#x2013;4175. doi: 10.1093/hmg/ddq335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq335</ArticleId><ArticleId IdType="pmc">PMC2981014</ArticleId><ArticleId IdType="pubmed">20699327</ArticleId></ArticleIdList></Reference><Reference><Citation>Daigle J.G., Krishnamurthy K., Ramesh N., Casci I., Monaghan J., McAvoy K., Godfrey E.W., Daniel D.C., Johnson E.M., Monahan Z., et al. Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity. Acta Neuropathol. 2016;131:605&#x2013;620. doi: 10.1007/s00401-015-1530-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1530-0</ArticleId><ArticleId IdType="pmc">PMC4791193</ArticleId><ArticleId IdType="pubmed">26728149</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal J., Zhang J., Kwinter D.M., Zhai J., Jia H., Jia J., Zhu H. Nuclear localization sequence of FUS and induction of stress granules by ALS mutants. Neurobiol. Aging. 2011;32:2323. doi: 10.1016/j.neurobiolaging.2010.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2010.06.010</ArticleId><ArticleId IdType="pmc">PMC2997923</ArticleId><ArticleId IdType="pubmed">20674093</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory R.I., Yan K.-P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., Shiekhattar R. The Microprocessor complex mediates the genesis of microRNAs. Nat. Cell Biol. 2004;432:235&#x2013;240. doi: 10.1038/nature03120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03120</ArticleId><ArticleId IdType="pubmed">15531877</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan A.Y., Manley J.L. TLS Inhibits RNA Polymerase III Transcription. Mol. Cell. Biol. 2009;30:186&#x2013;196. doi: 10.1128/MCB.00884-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00884-09</ArticleId><ArticleId IdType="pmc">PMC2798296</ArticleId><ArticleId IdType="pubmed">19841068</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Embree L.J., Tsai S., Hickstein D.D. Oncoprotein TLS Interacts with Serine-Arginine Proteins Involved in RNA Splicing. J. Biol. Chem. 1998;273:27761&#x2013;27764. doi: 10.1074/jbc.273.43.27761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.43.27761</ArticleId><ArticleId IdType="pubmed">9774382</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Arai S., Song X., Reichart D., Du K., Pascual G., Tempst P., Rosenfeld M.G., Glass C.K., Kurokawa R. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nat. Cell Biol. 2008;454:126&#x2013;130. doi: 10.1038/nature06992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06992</ArticleId><ArticleId IdType="pmc">PMC2823488</ArticleId><ArticleId IdType="pubmed">18509338</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunet M.A., Jacques J., Nassari S., Tyzack G.E., McGoldrick P., Zinman L., Jean S., Robertson J., Patani R., Roucou X. The FUS gene is dual-coding with both proteins contributing to FUS -mediated toxicity. EMBO Rep. 2021;22:e50640. doi: 10.15252/embr.202050640.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202050640</ArticleId><ArticleId IdType="pmc">PMC7788448</ArticleId><ArticleId IdType="pubmed">33226175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Modigliani S.D., Morlando M., Errichelli L., Sabatelli M., Bozzoni I. An ALS-associated mutation in the FUS 3&#x2032;-UTR disrupts a microRNA&#x2013;FUS regulatory circuitry. Nat. Commun. 2014;5:4335. doi: 10.1038/ncomms5335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5335</ArticleId><ArticleId IdType="pubmed">25004804</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M., Moncada A., Conte A., Lattante S., Marangi G., Luigetti M., Lucchini M., Mirabella M., Romano A., Del Grande A., et al. Mutations in the 3&#x2032; untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013;22:4748&#x2013;4755. doi: 10.1093/hmg/ddt328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt328</ArticleId><ArticleId IdType="pubmed">23847048</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K., Martinez F.J., Yeo G.W. Genetic mutations in RNA-binding proteins and their roles in ALS. Qual. Life Res. 2017;136:1193&#x2013;1214. doi: 10.1007/s00439-017-1830-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-017-1830-7</ArticleId><ArticleId IdType="pmc">PMC5602095</ArticleId><ArticleId IdType="pubmed">28762175</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z.-Y., Zhou Z.-R., Che C.-H., Liu C.-Y., He R.-L., Huang H.-P. Genetic epidemiology of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Lyashchenko A.K., Lu L., Nasrabady S.E., Elmaleh M., Mendelsohn M., Nemes A., Tapia J.C., Mentis G.Z., Shneider N.A. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 2016;7:10465. doi: 10.1038/ncomms10465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10465</ArticleId><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Pal A., Goswami A., Lojewski X., Japtok J., Vehlow A., Naujock M., G&#xfc;nther R., Jin M., Stanslowsky N., et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat. Commun. 2018;9:1&#x2013;17. doi: 10.1038/s41467-017-02299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.-C., Liang T.Y., Mazur C., et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Liu S., Liu G., &#xd6;zt&#xfc;rk A., Hicks G.G. ALS-Associated FUS Mutations Result in Compromised FUS Alternative Splicing and Autoregulation. PLoS Genet. 2013;9:e1003895. doi: 10.1371/journal.pgen.1003895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1003895</ArticleId><ArticleId IdType="pmc">PMC3814325</ArticleId><ArticleId IdType="pubmed">24204307</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T., Qamar S., Lin J.Q., Schierle G.S.K., Rees E., Miyashita A., Costa A.R., Dodd R.B., Chan F.T., Michel C.H., et al. ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function. Neuron. 2015;88:678&#x2013;690. doi: 10.1016/j.neuron.2015.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.030</ArticleId><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey J., Birsa N., Milioto C., McLaughlin M., Ule A.M., Robaldo D., Eberle A.B., Kr&#xe4;uchi R., Bentham M., Brown A.-L., et al. FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention. Nucleic Acids Res. 2020;48:6889&#x2013;6905. doi: 10.1093/nar/gkaa410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa410</ArticleId><ArticleId IdType="pmc">PMC7337901</ArticleId><ArticleId IdType="pubmed">32479602</ArticleId></ArticleIdList></Reference><Reference><Citation>An H., Skelt L., Notaro A., Highley J.R., Fox A.H., La Bella V., Buchman V.L., Shelkovnikova T.A. ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles. Acta Neuropathol. Commun. 2019;7:1&#x2013;14. doi: 10.1186/s40478-019-0658-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0658-x</ArticleId><ArticleId IdType="pmc">PMC6330737</ArticleId><ArticleId IdType="pubmed">30642400</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkening K., Leystra-Lantz C., Yang W., Jaffee H., Strong M.J. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS) Brain Res. 2009;1305:168&#x2013;182. doi: 10.1016/j.brainres.2009.09.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.09.105</ArticleId><ArticleId IdType="pubmed">19815002</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., Baralle F.E. Characterization and Functional Implications of the RNA Binding Properties of Nuclear Factor TDP-43, a Novel Splicing Regulator ofCFTR Exon 9. J. Biol. Chem. 2001;276:36337&#x2013;36343. doi: 10.1074/jbc.M104236200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M104236200</ArticleId><ArticleId IdType="pubmed">11470789</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk T.R., Rousseaux M.W.C. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol. Neurodegener. 2020;15:1&#x2013;16. doi: 10.1186/s13024-020-00397-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00397-1</ArticleId><ArticleId IdType="pmc">PMC7429473</ArticleId><ArticleId IdType="pubmed">32799899</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra J., Guerrero E.N., Hegde P.M., Liachko N.F., Wang H., Vasquez V., Gao J., Pandey A., Taylor J.P., Kraemer B.C., et al. Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proc. Natl. Acad. Sci. USA. 2019;116:4696&#x2013;4705. doi: 10.1073/pnas.1818415116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1818415116</ArticleId><ArticleId IdType="pmc">PMC6410842</ArticleId><ArticleId IdType="pubmed">30770445</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauer S., Zimyanin V., Hermann A. Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis. J. Neural Transm. 2018;125:591&#x2013;613. doi: 10.1007/s00702-018-1851-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-018-1851-y</ArticleId><ArticleId IdType="pubmed">29417336</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang W., Hu F. Cellular and physiological functions of C9ORF72 and implications for ALS/FTD. J. Neurochem. 2020 doi: 10.1111/jnc.15255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15255</ArticleId><ArticleId IdType="pubmed">33259633</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C., Campanari M., Corbier C.J., Gaucherot A., Kolb-Cheynel I., Oulad-Abdelghani M., Ruffenach F., Page A., Ciura S., Kabashi E., et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J. 2016;35:1276&#x2013;1297. doi: 10.15252/embj.201593350.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593350</ArticleId><ArticleId IdType="pmc">PMC4910533</ArticleId><ArticleId IdType="pubmed">27103069</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck J., Poulter M., Hensman D., Rohrer J.D., Mahoney C.J., Adamson G., Campbell T., Uphill J., Borg A., Fratta P., et al. Large C9ORF72 Hexanucleotide Repeat Expansions Are Seen in Multiple Neurodegenerative Syndromes and Are More Frequent Than Expected in the UK Population. Am. J. Hum. Genet. 2013;92:345&#x2013;353. doi: 10.1016/j.ajhg.2013.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2013.01.011</ArticleId><ArticleId IdType="pmc">PMC3591848</ArticleId><ArticleId IdType="pubmed">23434116</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B.N., Newhouse S., Shatunov A., Vance C., Topp S., Johnson L., Miller J.W., Lee Y., Troakes C., Scott K.M., et al. The C9ORF72 expansion mutation is a common cause of ALS+/&#x2212;FTD in Europe and has a single founder. Eur. J. Hum. Genet. 2012;21:102&#x2013;108. doi: 10.1038/ejhg.2012.98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2012.98</ArticleId><ArticleId IdType="pmc">PMC3522204</ArticleId><ArticleId IdType="pubmed">22692064</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepheard S.R., Parker M.D., Cooper-Knock J., Verber N.S., Tuddenham L., Heath P., Beauchamp N., Place E., Sollars E.S.A., Turner M.R., et al. Value of systematic genetic screening of patients with amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2021 doi: 10.1136/jnnp-2020-325014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-325014</ArticleId><ArticleId IdType="pmc">PMC8053339</ArticleId><ArticleId IdType="pubmed">33589474</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron T.F., Bieniek K.F., Zhang Y.-J., Jansen-West K., Ash P.E.A., Caulfield T., Daughrity L., Dunmore J.H., Castanedes-Casey M., Chew J., et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 2013;126:829&#x2013;844. doi: 10.1007/s00401-013-1192-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1192-8</ArticleId><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron T.F., Belzil V.V., Zhang Y.-J., Petrucelli L. Mechanisms of toxicity in C9FTLD/ALS. Acta Neuropathol. 2014;127:359&#x2013;376. doi: 10.1007/s00401-013-1237-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1237-z</ArticleId><ArticleId IdType="pmc">PMC4002260</ArticleId><ArticleId IdType="pubmed">24394885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash P.E., Bieniek K.F., Gendron T.F., Caulfield T., Lin W.-L., DeJesus-Hernandez M., van Blitterswijk M.M., Jansen-West K., Paul J.W., Rademakers R., et al. Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS. Neuron. 2013;77:639&#x2013;646. doi: 10.1016/j.neuron.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T., Gibbens B., Doty N.S., Gomes-Pereira M., Huguet A., Stone M.D., Margolis J., Peterson M., Markowski T.W., Ingram M.A.C., et al. Non-ATG&#x2013;initiated translation directed by microsatellite expansions. Proc. Natl. Acad. Sci. USA. 2010;108:260&#x2013;265. doi: 10.1073/pnas.1013343108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1013343108</ArticleId><ArticleId IdType="pmc">PMC3017129</ArticleId><ArticleId IdType="pubmed">21173221</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleary J.D., Ranum L.P. New developments in RAN translation: Insights from multiple diseases. Curr. Opin. Genet. Dev. 2017;44:125&#x2013;134. doi: 10.1016/j.gde.2017.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gde.2017.03.006</ArticleId><ArticleId IdType="pmc">PMC5951168</ArticleId><ArticleId IdType="pubmed">28365506</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite A.J., B&#xe4;umer D., East S., Neal J., Morris H.R., Ansorge O., Blake D.J. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol. Aging. 2014;35:1779. doi: 10.1016/j.neurobiolaging.2014.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.01.016</ArticleId><ArticleId IdType="pmc">PMC3988882</ArticleId><ArticleId IdType="pubmed">24559645</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B., Gendron T.F., Staff N.P. Amyotrophic Lateral Sclerosis: An Update for 2018. Mayo Clin. Proc. 2018;93:1617&#x2013;1628. doi: 10.1016/j.mayocp.2018.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2018.04.007</ArticleId><ArticleId IdType="pubmed">30401437</ArticleId></ArticleIdList></Reference><Reference><Citation>Silani V., Ludolph A., Fornai F. The emerging picture of ALS: A multisystem, not only a &#x201c;motor neuron disease&#x201d;. Arch. Ital. Biol. 2018;155:153&#x2013;158. doi: 10.12871/00039829201741.</Citation><ArticleIdList><ArticleId IdType="doi">10.12871/00039829201741</ArticleId><ArticleId IdType="pubmed">29405027</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert E.H., Mulder D.W. Electromyographic studies in amyotrophic lateral sclerosis. Proc. Staff. Meet. Mayo Clin. 1957;32:441&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">13465824</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilbourn A.J. Clinical neurophysiology in the diagnosis of amyotrophic lateral sclerosis: The Lambert and the El Escorial criteria. J. Neurol. Sci. 1998;160:S25&#x2013;S29. doi: 10.1016/S0022-510X(98)00194-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(98)00194-4</ArticleId><ArticleId IdType="pubmed">9851644</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A.C., Drory V.E., Hardiman O., Nakano I., Ravits J., Robberecht W., Shefner J.M., WFN Research Group on ALS/MND A revision of the El Escorial criteria&#x2014;2015. Amyotroph. Lateral Scler. Front. Degener. 2015;16:291&#x2013;292. doi: 10.3109/21678421.2015.1049183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D.-W., Liu M., Cui B., Fang J., Guan Y.-Z., Ding Q., Li X., Cui L. The Awaji criteria increases the diagnostic sensitivity of the revised El Escorial criteria for amyotrophic lateral sclerosis diagnosis in a Chinese population. PLoS ONE. 2017;12:e0171522. doi: 10.1371/journal.pone.0171522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0171522</ArticleId><ArticleId IdType="pmc">PMC5332033</ArticleId><ArticleId IdType="pubmed">28249004</ArticleId></ArticleIdList></Reference><Reference><Citation>Verde F., Del Tredici K., Braak H. The multisystem degeneration amyotrophic lateral sclerosis&#x2014;Neuropathological staging and clinical translation. Arch. Ital. Biol. 2018;155:210&#x2013;227. doi: 10.12871/00039829201746.</Citation><ArticleIdList><ArticleId IdType="doi">10.12871/00039829201746</ArticleId><ArticleId IdType="pubmed">29405032</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo M., Lee S., Jeon Y.-M., Kim S., Kwon Y., Kim H.-J. The role of TDP-43 propagation in neurodegenerative diseases: Integrating insights from clinical and experimental studies. Exp. Mol. Med. 2020;52:1652&#x2013;1662. doi: 10.1038/s12276-020-00513-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-020-00513-7</ArticleId><ArticleId IdType="pmc">PMC8080625</ArticleId><ArticleId IdType="pubmed">33051572</ArticleId></ArticleIdList></Reference><Reference><Citation>Riku Y. Reappraisal of the anatomical spreading and propagation hypothesis about TDP-43 aggregation in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Neuropathology. 2020;40:426&#x2013;435. doi: 10.1111/neup.12644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12644</ArticleId><ArticleId IdType="pubmed">32157757</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;t&#x11b;tk&#xe1;&#x159;ov&#xe1; I., Ehler E. Diagnostics of Amyotrophic Lateral Sclerosis: Up to Date. Diagnostics. 2021;11:231. doi: 10.3390/diagnostics11020231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11020231</ArticleId><ArticleId IdType="pmc">PMC7913557</ArticleId><ArticleId IdType="pubmed">33546386</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman N.R., Durham H.D., Blusztajn J.K., Oda K., Tabira T., Shaw I.T., Dahrouge S., Antel J.P. Neuroblastoma &#xd7; spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 1992;194:209&#x2013;221. doi: 10.1002/aja.1001940306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aja.1001940306</ArticleId><ArticleId IdType="pubmed">1467557</ArticleId></ArticleIdList></Reference><Reference><Citation>Cookson M.R., Menzies F.M., Manning P., Eggett C.J., Figlewicz D.A., McNeil C.J., Shaw P.J. Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress. Amyotroph. Lateral Scler. 2002;3:75&#x2013;85. doi: 10.1080/146608202760196048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608202760196048</ArticleId><ArticleId IdType="pubmed">12215229</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S., Heath P.R., Kirby J., Wharton S.B., Cookson M.R., Menzies F.M., Banks R.E., Shaw P.J. Analysis of the Cytosolic Proteome in a Cell Culture Model of Familial Amyotrophic Lateral Sclerosis Reveals Alterations to the Proteasome, Antioxidant Defenses, and Nitric Oxide Synthetic Pathways. J. Biol. Chem. 2003;278:6371&#x2013;6383. doi: 10.1074/jbc.M209915200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M209915200</ArticleId><ArticleId IdType="pubmed">12475980</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzardini M., Mangolini A., Lupi M., Ubezio P., Bendotti C., Cantoni L. Low levels of ALS-linked Cu/Zn superoxide dismutase increase the production of reactive oxygen species and cause mitochondrial damage and death in motor neuron-like cells. J. Neurol. Sci. 2005;232:95&#x2013;103. doi: 10.1016/j.jns.2005.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2005.02.004</ArticleId><ArticleId IdType="pubmed">15850589</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri A., Cozzolino M., Crosio C., Nencini M., Casciati A., Gralla E.B., Rotilio G., Valentine J.S., Carr&#xec; M.T. Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials. Proc. Natl. Acad. Sci. USA. 2006;103:13860&#x2013;13865. doi: 10.1073/pnas.0605814103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0605814103</ArticleId><ArticleId IdType="pmc">PMC1557633</ArticleId><ArticleId IdType="pubmed">16945901</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C., Palma A.S., Almeida R., Regalla M., McCluskey L.F., Trojanowski J.Q., Costa J. Establishment of a cell model of ALS disease: Golgi apparatus disruption occurs independently from apoptosis. Biotechnol. Lett. 2007;30:603&#x2013;610. doi: 10.1007/s10529-007-9595-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10529-007-9595-z</ArticleId><ArticleId IdType="pubmed">18004513</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala G., Beretta S., Ceresa C., Mattavelli L., Zoia C., Tremolizzo L., Ferri A., Carr&#xec; M.T., Ferrarese C. Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis. Neurochem. Int. 2005;46:227&#x2013;234. doi: 10.1016/j.neuint.2004.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2004.10.002</ArticleId><ArticleId IdType="pubmed">15670639</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu W., Liu X., Wang S., Sun G., Zhao R., Lu H. SecinH3 Attenuates TDP-43 p.Q331K-Induced Neuronal Toxicity by Suppressing Endoplasmic Reticulum Stress and Enhancing Autophagic Flux. IUBMB Life. 2019;71:192&#x2013;199. doi: 10.1002/iub.1951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1951</ArticleId><ArticleId IdType="pubmed">30376609</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannini M., Bayona-Feliu A., Sproviero D., Barroso S.I., Cereda C., Aguilera A. TDP-43 mutations link Amyotrophic Lateral Sclerosis with R-loop homeostasis and R loop-mediated DNA damage. PLoS Genet. 2020;16:e1009260. doi: 10.1371/journal.pgen.1009260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1009260</ArticleId><ArticleId IdType="pmc">PMC7755276</ArticleId><ArticleId IdType="pubmed">33301444</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell. 2007;131:861&#x2013;872. doi: 10.1016/j.cell.2007.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.11.019</ArticleId><ArticleId IdType="pubmed">18035408</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.-Y., Ting H.-C., Liu C.-A., Su H.-L., Chiou T.-W., Lin S.-Z., Harn H.-J., Ho T.-J. Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening. Molecules. 2020;25:2000. doi: 10.3390/molecules25082000.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25082000</ArticleId><ArticleId IdType="pmc">PMC7221979</ArticleId><ArticleId IdType="pubmed">32344649</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagiannis P., Inoue H. ALS, a cellular whodunit on motor neuron degeneration. Mol. Cell. Neurosci. 2020;107:103524. doi: 10.1016/j.mcn.2020.103524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2020.103524</ArticleId><ArticleId IdType="pubmed">32629110</ArticleId></ArticleIdList></Reference><Reference><Citation>Goffeau A., Barrell B.G., Bussey H., Davis R.W., Dujon B., Feldmann H., Galibert F., Hoheisel J.D., Jacq C., Johnston M., et al. Life with 6000 Genes. Science. 1996;274:546&#x2013;567. doi: 10.1126/science.274.5287.546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.274.5287.546</ArticleId><ArticleId IdType="pubmed">8849441</ArticleId></ArticleIdList></Reference><Reference><Citation>Kryndushkin D., Shewmaker F. Modeling ALS and FTLD proteinopathies in yeast: An efficient approach for studying protein aggregation and toxicity. Prion. 2011;5:250&#x2013;257. doi: 10.4161/pri.17229.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.17229</ArticleId><ArticleId IdType="pmc">PMC4012400</ArticleId><ArticleId IdType="pubmed">22052354</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernoff Y.O., Grizel A.V., Rubel A.A., Zelinsky A.A., Chandramowlishwaran P., Chernova T.A. Application of yeast to studying amyloid and prion diseases. Adv. Genet. 2020;105:293&#x2013;380. doi: 10.1016/bs.adgen.2020.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.adgen.2020.01.002</ArticleId><ArticleId IdType="pmc">PMC7527210</ArticleId><ArticleId IdType="pubmed">32560789</ArticleId></ArticleIdList></Reference><Reference><Citation>Rencus-Lazar S., DeRowe Y., Adsi H., Gazit E., Laor D. Yeast Models for the Study of Amyloid-Associated Disorders and Development of Future Therapy. Front. Mol. Biosci. 2019;6:15. doi: 10.3389/fmolb.2019.00015.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2019.00015</ArticleId><ArticleId IdType="pmc">PMC6439353</ArticleId><ArticleId IdType="pubmed">30968029</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gregorio S.E., Duennwald M.L. ALS Yeast Models&#x2014;Past Success Stories and New Opportunities. Front. Mol. Neurosci. 2018;11:394. doi: 10.3389/fnmol.2018.00394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00394</ArticleId><ArticleId IdType="pmc">PMC6218427</ArticleId><ArticleId IdType="pubmed">30425620</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden A.C., Kim H.-J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X., Armakola M., Geser F., Greene R., Lu M.M., et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nat. Cell Biol. 2010;466:1069&#x2013;1075. doi: 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.-J., Raphael A.R., LaDow E.S., McGurk L., Weber R.A., Trojanowski J.Q., Lee V.M.-Y., Finkbeiner S., Gitler A.D., Bonini N.M. Therapeutic modulation of eIF2&#x3b1; phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat. Genet. 2014;46:152&#x2013;160. doi: 10.1038/ng.2853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2853</ArticleId><ArticleId IdType="pmc">PMC3934366</ArticleId><ArticleId IdType="pubmed">24336168</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;i&#x107; A., Mertens J., Boeynaems S., Bogaert E., Chai N., Yamada S.B., Paul J.W., Sun S., Herdy J.R., Bieri G., et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat. Neurosci. 2015;18:1226&#x2013;1229. doi: 10.1038/nn.4085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4085</ArticleId><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastow E.L., Peswani A.R., Tarrant D.S.J., Pentland D.R., Chen X., Morgan A., Staniforth G.L., Tullet J.M., Rowe M.L., Howard M.J., et al. New links between SOD1 and metabolic dysfunction from a yeast model of Amyotrophic Lateral Sclerosis (ALS) J. Cell Sci. 2016;129:4118&#x2013;4129. doi: 10.1242/jcs.190298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.190298</ArticleId><ArticleId IdType="pmc">PMC5117206</ArticleId><ArticleId IdType="pubmed">27656112</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasil A.D.A., De Carvalho M.D.C., Gerhardt E., Queiroz D.D., Pereira M.D., Outeiro T.F., Eleutherio E.C.A. Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1. Proc. Natl. Acad. Sci. USA. 2019;116:25991&#x2013;26000. doi: 10.1073/pnas.1902483116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1902483116</ArticleId><ArticleId IdType="pmc">PMC6926019</ArticleId><ArticleId IdType="pubmed">31796595</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabizadeh S., Gralla E.B., Borchelt D.R., Gwinn R., Valentine J.S., Sisodia S., Wong P., Lee M., Hahn H., Bredesen D.E. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: Studies in yeast and neural cells. Proc. Natl. Acad. Sci. USA. 1995;92:3024&#x2013;3028. doi: 10.1073/pnas.92.7.3024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.7.3024</ArticleId><ArticleId IdType="pmc">PMC42351</ArticleId><ArticleId IdType="pubmed">7708768</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.-K., Arslan F., Kanneganti V., Barmada S.J., Purushothaman P., Verma S.C., Liebman S.W. Overexpression of a conserved HSP40 chaperone reduces toxicity of several neurodegenerative disease proteins. Prion. 2018;12:16&#x2013;22. doi: 10.1080/19336896.2017.1423185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2017.1423185</ArticleId><ArticleId IdType="pmc">PMC5871033</ArticleId><ArticleId IdType="pubmed">29308690</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z., Diaz Z., Fang X., Hart M.P., Chesi A., Shorter J., Gitler A.D. Molecular Determinants and Genetic Modifiers of Aggregation and Toxicity for the ALS Disease Protein FUS/TLS. PLoS Biol. 2011;9:e1000614. doi: 10.1371/journal.pbio.1000614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000614</ArticleId><ArticleId IdType="pmc">PMC3082519</ArticleId><ArticleId IdType="pubmed">21541367</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju S., Tardiff D.F., Han H., Divya K., Zhong Q., Maquat L.E., Bosco D.A., Hayward L.J., Brown R.H., Jr., Lindquist S., et al. A Yeast Model of FUS/TLS-Dependent Cytotoxicity. PLoS Biol. 2011;9:e1001052. doi: 10.1371/journal.pbio.1001052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1001052</ArticleId><ArticleId IdType="pmc">PMC3082520</ArticleId><ArticleId IdType="pubmed">21541368</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden E., Chen S., Chumley A., Xia C., Zhong Q., Ju S. A Genetic Screen for Human Genes Suppressing FUS Induced Toxicity in Yeast. G3 Genes Genomes Genet. 2020;10:1843&#x2013;1852. doi: 10.1534/g3.120.401164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/g3.120.401164</ArticleId><ArticleId IdType="pmc">PMC7263679</ArticleId><ArticleId IdType="pubmed">32276960</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson B.S., Snead D., Lee J.J., McCaffery J.M., Shorter J., Gitler A.D. TDP-43 Is Intrinsically Aggregation-prone, and Amyotrophic Lateral Sclerosis-linked Mutations Accelerate Aggregation and Increase Toxicity. J. Biol. Chem. 2009;284:20329&#x2013;20339. doi: 10.1074/jbc.M109.010264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.010264</ArticleId><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson B.S., McCaffery J.M., Lindquist S., Gitler A.D. A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA. 2008;105:6439&#x2013;6444. doi: 10.1073/pnas.0802082105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0802082105</ArticleId><ArticleId IdType="pmc">PMC2359814</ArticleId><ArticleId IdType="pubmed">18434538</ArticleId></ArticleIdList></Reference><Reference><Citation>Armakola M., Higgins M.J., Figley M.D., Barmada S.J., Scarborough E.A., Diaz Z., Fang X., Shorter J., Krogan N.J., Finkbeiner S., et al. Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nat. Genet. 2012;44:1302&#x2013;1309. doi: 10.1038/ng.2434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2434</ArticleId><ArticleId IdType="pmc">PMC3510335</ArticleId><ArticleId IdType="pubmed">23104007</ArticleId></ArticleIdList></Reference><Reference><Citation>Figley M.D., Gitler A.D. Yeast genetic screen reveals novel therapeutic strategy for ALS. Rare Dis. 2013;1:e24420. doi: 10.4161/rdis.24420.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rdis.24420</ArticleId><ArticleId IdType="pmc">PMC3933050</ArticleId><ArticleId IdType="pubmed">25002991</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharathi V., Girdhar A., Patel B.K. Role of CNC1 gene in TDP-43 aggregation-induced oxidative stress-mediated cell death in S. cerevisiae model of ALS. BBA Mol. Cell Res. 2021;1868:118993. doi: 10.1016/j.bbamcr.2021.118993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2021.118993</ArticleId><ArticleId IdType="pubmed">33647321</ArticleId></ArticleIdList></Reference><Reference><Citation>Yemini E., Jucikas T., Grundy L.J., Brown A.E., Schafer W.R. A database of Caenorhabditis elegans behavioral phenotypes. Nat. Methods. 2013;10:877&#x2013;879. doi: 10.1038/nmeth.2560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2560</ArticleId><ArticleId IdType="pmc">PMC3962822</ArticleId><ArticleId IdType="pubmed">23852451</ArticleId></ArticleIdList></Reference><Reference><Citation>Therrien M., Parker J.A. Worming forward: Amyotrophic lateral sclerosis toxicity mechanisms and genetic interactions in Caenorhabditis elegans. Front. Genet. 2014;5:85. doi: 10.3389/fgene.2014.00085.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2014.00085</ArticleId><ArticleId IdType="pmc">PMC4029022</ArticleId><ArticleId IdType="pubmed">24860590</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldwell K.A., Willicott C.W., Caldwell G.A. Modeling neurodegeneration in Caenorhabditis elegans. Dis. Model. Mech. 2020;13:dmm046110. doi: 10.1242/dmm.046110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.046110</ArticleId><ArticleId IdType="pmc">PMC7648605</ArticleId><ArticleId IdType="pubmed">33106318</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeda T., Shimohama S., Kitagawa N., Kohno R., Imura T., Shibasaki H., Ishii N. Oxidative stress causes abnormal accumulation of familial amyotrophic lateral sclerosis-related mutant SOD1 in transgenic Caenorhabditis elegans. Hum. Mol. Genet. 2001;10:2013&#x2013;2023. doi: 10.1093/hmg/10.19.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/10.19.2013</ArticleId><ArticleId IdType="pubmed">11590119</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Farr G.W., Hall D.H., Li F., Furtak K., Dreier L., Horwich A.L. An ALS-Linked Mutant SOD1 Produces a Locomotor Defect Associated with Aggregation and Synaptic Dysfunction When Expressed in Neurons of Caenorhabditis elegans. PLoS Genet. 2009;5:e1000350. doi: 10.1371/journal.pgen.1000350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000350</ArticleId><ArticleId IdType="pmc">PMC2621352</ArticleId><ArticleId IdType="pubmed">19165329</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskoylu S.N., Yersak J., O&#x2019;Hern P., Grosser S., Simon J., Kim S., Schuch K., Dimitriadi M., Yanagi K.S., Lins J., et al. Single copy/knock-in models of ALS SOD1 in C. elegans suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration. PLoS Genet. 2018;14:e1007682. doi: 10.1371/journal.pgen.1007682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007682</ArticleId><ArticleId IdType="pmc">PMC6200258</ArticleId><ArticleId IdType="pubmed">30296255</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T., Yang S.-P., Xie L., Kawano T., Fu D., Mukai A., Bohm C., Chen F., Robertson J., Suzuki H., et al. ALS mutations in FUS cause neuronal dysfunction and death in Caenorhabditis elegans by a dominant gain-of-function mechanism. Hum. Mol. Genet. 2011;21:1&#x2013;9. doi: 10.1093/hmg/ddr417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr417</ArticleId><ArticleId IdType="pmc">PMC3235006</ArticleId><ArticleId IdType="pubmed">21949354</ArticleId></ArticleIdList></Reference><Reference><Citation>Markert S.M., Skoruppa M., Yu B., Mulcahy B., Zhen M., Gao S., Sendtner M., Stigloher C. Overexpression of an ALS-associated FUS mutation in C. elegans disrupts NMJ morphology and leads to defective neuromuscular transmission. Biol. Open. 2020;9:bio055129. doi: 10.1242/bio.055129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/bio.055129</ArticleId><ArticleId IdType="pmc">PMC7746668</ArticleId><ArticleId IdType="pubmed">33148607</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash P.E., Zhang Y.-J., Roberts C.M., Saldi T., Hutter H., Buratti E., Petrucelli L., Link C.D. Neurotoxic effects of TDP-43 overexpression in C. elegans. Hum. Mol. Genet. 2010;19:3206&#x2013;3218. doi: 10.1093/hmg/ddq230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq230</ArticleId><ArticleId IdType="pmc">PMC2908471</ArticleId><ArticleId IdType="pubmed">20530643</ArticleId></ArticleIdList></Reference><Reference><Citation>Liachko N.F., Guthrie C.R., Kraemer B.C. Phosphorylation Promotes Neurotoxicity in a Caenorhabditis elegans Model of TDP-43 Proteinopathy. J. Neurosci. 2010;30:16208&#x2013;16219. doi: 10.1523/JNEUROSCI.2911-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2911-10.2010</ArticleId><ArticleId IdType="pmc">PMC3075589</ArticleId><ArticleId IdType="pubmed">21123567</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccaro A., Tauffenberger A., Aggad D., Rouleau G., Drapeau P., Parker J.A. Mutant TDP-43 and FUS Cause Age-Dependent Paralysis and Neurodegeneration in C. elegans. PLoS ONE. 2012;7:e31321. doi: 10.1371/journal.pone.0031321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0031321</ArticleId><ArticleId IdType="pmc">PMC3283630</ArticleId><ArticleId IdType="pubmed">22363618</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccaro A., Tauffenberger A., Ash P.E.A., Carlomagno Y., Petrucelli L., Parker J.A. TDP-1/TDP-43 Regulates Stress Signaling and Age-Dependent Proteotoxicity in Caenorhabditis elegans. PLoS Genet. 2012;8:e1002806. doi: 10.1371/journal.pgen.1002806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002806</ArticleId><ArticleId IdType="pmc">PMC3390363</ArticleId><ArticleId IdType="pubmed">22792076</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong S.Q., Pontifex M.G., Phelan M.M., Pidathala C., Kraemer B.C., Barclay J.W., Berry N.G., O&#x2019;Neill P.M., Burgoyne R.D., Morgan A. &#x3b1;-Methyl-&#x3b1;-phenylsuccinimide ameliorates neurodegeneration in a C. elegans model of TDP-43 proteinopathy. Neurobiol. Dis. 2018;118:40&#x2013;54. doi: 10.1016/j.nbd.2018.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.06.013</ArticleId><ArticleId IdType="pmc">PMC6097874</ArticleId><ArticleId IdType="pubmed">29940336</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas-Prats E., Martinez-Gonzalez L., Gonzalo-Consuegra C., Liachko N.F., Perez C., Ram&#xed;rez D., Kraemer B.C., Martin-Requero &#xc1;., Perez D.I., Gil C., et al. Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis. Eur. J. Med. Chem. 2021;210:112968. doi: 10.1016/j.ejmech.2020.112968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2020.112968</ArticleId><ArticleId IdType="pubmed">33139113</ArticleId></ArticleIdList></Reference><Reference><Citation>Therrien M., Rouleau G.A., Dion P.A., Parker J.A. Deletion of C9ORF72 Results in Motor Neuron Degeneration and Stress Sensitivity in C. elegans. PLoS ONE. 2013;8:e83450. doi: 10.1371/journal.pone.0083450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083450</ArticleId><ArticleId IdType="pmc">PMC3861484</ArticleId><ArticleId IdType="pubmed">24349511</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Hao L., Saur T., Joyal K., Zhao Y., Zhai D., Li J., Pribadi M., Coppola G., Cohen B.M., et al. Forward Genetic Screen in Caenorhabditis elegans Suggests F57A10.2 and acp-4 as Suppressors of C9ORF72 Related Phenotypes. Front. Mol. Neurosci. 2016;9:113. doi: 10.3389/fnmol.2016.00113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00113</ArticleId><ArticleId IdType="pmc">PMC5100550</ArticleId><ArticleId IdType="pubmed">27877110</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand A.H., Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 1993;118:401&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pubmed">8223268</ArticleId></ArticleIdList></Reference><Reference><Citation>Caygill E.E., Brand A.H. The GAL4 System: A Versatile System for the Manipulation and Analysis of Gene Expression. Methods Mol. Biol. 2016;1478:33&#x2013;52. doi: 10.1007/978-1-4939-6371-3_2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-6371-3_2</ArticleId><ArticleId IdType="pubmed">27730574</ArticleId></ArticleIdList></Reference><Reference><Citation>Potter C.J., Tasic B., Russler E.V., Liang L., Luo L. The Q System: A Repressible Binary System for Transgene Expression, Lineage Tracing, and Mosaic Analysis. Cell. 2010;141:536&#x2013;548. doi: 10.1016/j.cell.2010.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.02.025</ArticleId><ArticleId IdType="pmc">PMC2883883</ArticleId><ArticleId IdType="pubmed">20434990</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai S.-L., Lee T. Genetic mosaic with dual binary transcriptional systems in Drosophila. Nat. Neurosci. 2006;9:703&#x2013;709. doi: 10.1038/nn1681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1681</ArticleId><ArticleId IdType="pubmed">16582903</ArticleId></ArticleIdList></Reference><Reference><Citation>Azuma Y., Mizuta I., Tokuda T., Mizuno T. Amyotrophic Lateral Sclerosis Model. Adv. Exp. Med. Biol. 2018;1076:79&#x2013;95. doi: 10.1007/978-981-13-0529-0_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-0529-0_6</ArticleId><ArticleId IdType="pubmed">29951816</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi M., Omori K., Asada S., Yoshida H. Epigenetic Regulation of ALS and CMT: A Lesson from Drosophila Models. Int. J. Mol. Sci. 2021;22:491. doi: 10.3390/ijms22020491.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22020491</ArticleId><ArticleId IdType="pmc">PMC7825332</ArticleId><ArticleId IdType="pubmed">33419039</ArticleId></ArticleIdList></Reference><Reference><Citation>Layalle S., They L., Ourghani S., Raoul C., Soustelle L. Amyotrophic Lateral Sclerosis Genes in Drosophila melanogaster. Int. J. Mol. Sci. 2021;22:904. doi: 10.3390/ijms22020904.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22020904</ArticleId><ArticleId IdType="pmc">PMC7831090</ArticleId><ArticleId IdType="pubmed">33477509</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson M.R., Lagow R.D., Xu K., Zhang B., Bonini N.M. A Drosophila Model for Amyotrophic Lateral Sclerosis Reveals Motor Neuron Damage by Human SOD1. J. Biol. Chem. 2008;283:24972&#x2013;24981. doi: 10.1074/jbc.M804817200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M804817200</ArticleId><ArticleId IdType="pmc">PMC2529125</ArticleId><ArticleId IdType="pubmed">18596033</ArticleId></ArticleIdList></Reference><Reference><Citation>Elia A.J., Parkes T.L., Kirby K., George-Hyslop P.S., Boulianne G.-H.L., Phillips J.P., Hilliker A.J., St P. Expression of human FALS SOD in motorneurons of Drosophila. Free. Radic. Biol. Med. 1999;26:1332&#x2013;1338. doi: 10.1016/S0891-5849(98)00333-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(98)00333-5</ArticleId><ArticleId IdType="pubmed">10381207</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahadorani S., Mukai S.T., Rabie J., Beckman J.S., Phillips J.P., Hilliker A.J. Expression of zinc-deficient human superoxide dismutase in Drosophila neurons produces a locomotor defect linked to mitochondrial dysfunction. Neurobiol. Aging. 2013;34:2322&#x2013;2330. doi: 10.1016/j.neurobiolaging.2013.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.03.024</ArticleId><ArticleId IdType="pmc">PMC4145400</ArticleId><ArticleId IdType="pubmed">23601674</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Liang W., Wang H., Yang Y., Wang T., Wang S., Wang X., Wang Y., Feng H. &#x3b3;-Oryzanol mitigates oxidative stress and prevents mutant SOD1-Related neurotoxicity in Drosophila and cell models of amyotrophic lateral sclerosis. Neuropharmacology. 2019;160:107777. doi: 10.1016/j.neuropharm.2019.107777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2019.107777</ArticleId><ArticleId IdType="pubmed">31521619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Yang Y., Liang W., Wang T., Wang S., Wang X., Wang Y., Jiang H., Feng H. Neuroprotection by urate on the mutant hSOD1-related cellular and Drosophila models of amyotrophic lateral sclerosis: Implication for GSH synthesis via activating Akt/GSK3&#x3b2;/Nrf2/GCLC pathways. Brain Res. Bull. 2019;146:287&#x2013;301. doi: 10.1016/j.brainresbull.2019.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2019.01.019</ArticleId><ArticleId IdType="pubmed">30690059</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Cheng J., Wang S., Wang X., Jiang H., Yang Y., Wang Y., Zhang C., Liang W., Feng H. &#x3b1;-Lipoic acid attenuates oxidative stress and neurotoxicity via the ERK/Akt-dependent pathway in the mutant hSOD1 related Drosophila model and the NSC34 cell line of amyotrophic lateral sclerosis. Brain Res. Bull. 2018;140:299&#x2013;310. doi: 10.1016/j.brainresbull.2018.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2018.05.019</ArticleId><ArticleId IdType="pubmed">29842900</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Wang S., Wang X., Jiang H., Yang Y., Wang Y., Cheng J., Zhang C., Liang W., Feng H. Fisetin Exerts Antioxidant and Neuroprotective Effects in Multiple Mutant hSOD1 Models of Amyotrophic Lateral Sclerosis by Activating ERK. Neuroscience. 2018;379:152&#x2013;166. doi: 10.1016/j.neuroscience.2018.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2018.03.008</ArticleId><ArticleId IdType="pubmed">29559385</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rose F., Marotta R., Talani G., Catelani T., Solari P., Poddighe S., Borghero G., Marrosu F., Sanna E., Kasture S., et al. Differential effects of phytotherapic preparations in the hSOD1 Drosophila melanogaster model of ALS. Sci. Rep. 2017;7:41059. doi: 10.1038/srep41059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41059</ArticleId><ArticleId IdType="pmc">PMC5244478</ArticleId><ArticleId IdType="pubmed">28102336</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Yang M., Deng J., Chen X., Ye Y., Zhu L., Liu J., Ye H., Shen Y., Li Y., et al. Expression of human FUS protein in Drosophila leads to progressive neurodegeneration. Protein Cell. 2011;2:477&#x2013;486. doi: 10.1007/s13238-011-1065-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-011-1065-7</ArticleId><ArticleId IdType="pmc">PMC3563268</ArticleId><ArticleId IdType="pubmed">21748598</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasayama H., Shimamura M., Tokuda T., Azuma Y., Yoshida T., Mizuno T., Nakagawa M., Fujikake N., Nagai Y., Yamaguchi M. Knockdown of the Drosophila Fused in Sarcoma (FUS) Homologue Causes Deficient Locomotive Behavior and Shortening of Motoneuron Terminal Branches. PLoS ONE. 2012;7:e39483. doi: 10.1371/journal.pone.0039483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039483</ArticleId><ArticleId IdType="pmc">PMC3378546</ArticleId><ArticleId IdType="pubmed">22724023</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin K.R., Godena V.K., Hewitt V.L., Whitworth A.J. Axonal transport defects are a common phenotype in Drosophila models of ALS. Hum. Mol. Genet. 2016;25:2378&#x2013;2392. doi: 10.1093/hmg/ddw105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw105</ArticleId><ArticleId IdType="pmc">PMC5181624</ArticleId><ArticleId IdType="pubmed">27056981</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanson N.A., Maltare A., King H., Smith R., Kim J.H., Taylor J.P., Lloyd T.E., Pandey U.B. A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43. Hum. Mol. Genet. 2011;20:2510&#x2013;2523. doi: 10.1093/hmg/ddr150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr150</ArticleId><ArticleId IdType="pmc">PMC4288133</ArticleId><ArticleId IdType="pubmed">21487023</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.-W., Brent J.R., Tomlinson A., Shneider N.A., McCabe B.D. The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. J. Clin. Investig. 2011;121:4118&#x2013;4126. doi: 10.1172/JCI57883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI57883</ArticleId><ArticleId IdType="pmc">PMC3195475</ArticleId><ArticleId IdType="pubmed">21881207</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyaert J., Scheveneels W., Vanneste J., Van Damme P., Robberecht W., Callaerts P., Bogaert E., Bosch L.V.D. FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins. Hum. Mol. Genet. 2018;27:4103&#x2013;4116. doi: 10.1093/hmg/ddy303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy303</ArticleId><ArticleId IdType="pmc">PMC6240733</ArticleId><ArticleId IdType="pubmed">30379317</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C., Khalil B., Smith C.L., Rossoll W. Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD. Neurobiol. Dis. 2020;140:104835. doi: 10.1016/j.nbd.2020.104835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104835</ArticleId><ArticleId IdType="pmc">PMC7253339</ArticleId><ArticleId IdType="pubmed">32179176</ArticleId></ArticleIdList></Reference><Reference><Citation>Kankel M.W., Sen A., Lu L., Theodorou M., Dimlich D.N., McCampbell A., Henderson C.E., Shneider N.A., Artavanis-Tsakonas S. Amyotrophic Lateral Sclerosis Modifiers in Drosophila Reveal the Phospholipase D Pathway as a Potential Therapeutic Target. Genetics. 2020;215:747&#x2013;766. doi: 10.1534/genetics.119.302985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.119.302985</ArticleId><ArticleId IdType="pmc">PMC7337071</ArticleId><ArticleId IdType="pubmed">32345615</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., et al. Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS. Neuron. 2010;68:857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Azuma Y., Tokuda T., Shimamura M., Kyotani A., Sasayama H., Yoshida T., Mizuta I., Mizuno T., Nakagawa M., Fujikake N., et al. Identification of ter94, Drosophila VCP, as a strong modulator of motor neuron degeneration induced by knockdown of Caz, Drosophila FUS. Hum. Mol. Genet. 2014;23:3467&#x2013;3480. doi: 10.1093/hmg/ddu055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu055</ArticleId><ArticleId IdType="pubmed">24497576</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallik M., Catinozzi M., Hug C.B., Zhang L., Wagner M., Bussmann J., Bittern J., Mersmann S., Kl&#xe4;mbt C., Drexler H.C., et al. Xrp1 genetically interacts with the ALS-associated FUS orthologue caz and mediates its toxicity. J. Cell Biol. 2018;217:3947&#x2013;3964. doi: 10.1083/jcb.201802151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201802151</ArticleId><ArticleId IdType="pmc">PMC6219715</ArticleId><ArticleId IdType="pubmed">30209068</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Salvio M., Piccinni V., Gerbino V., Mantoni F., Camerini S., Lenzi J., Rosa A.L., Chellini L., Loreni F., Carri M.T., et al. Pur-alpha functionally interacts with FUS carrying ALS-associated mutations. Cell Death Dis. 2015;6:e1943. doi: 10.1038/cddis.2015.295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2015.295</ArticleId><ArticleId IdType="pmc">PMC4632316</ArticleId><ArticleId IdType="pubmed">26492376</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakisaka K.T., Tanaka R., Hirashima T., Muraoka Y., Azuma Y., Yoshida H., Tokuda T., Asada S., Suda K., Ichiyanagi K., et al. Novel roles of Drosophila FUS and Aub responsible for piRNA biogenesis in neuronal disorders. Brain Res. 2019;1708:207&#x2013;219. doi: 10.1016/j.brainres.2018.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.12.028</ArticleId><ArticleId IdType="pubmed">30578769</ArticleId></ArticleIdList></Reference><Reference><Citation>Casci I., Krishnamurthy K., Kour S., Tripathy V., Ramesh N., Anderson E.N., Marrone L., Grant R.A., Oliver S., Gochenaur L., et al. Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization. Nat. Commun. 2019;10:1&#x2013;20. doi: 10.1038/s41467-019-13383-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13383-z</ArticleId><ArticleId IdType="pmc">PMC6898697</ArticleId><ArticleId IdType="pubmed">31811140</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Scotter E.L., Nishimura A.L., Troakes C., Mitchell J.C., Kathe C., Urwin H., Manser C., Miller C.C., Hortob&#xe1;gyi T., et al. ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules. Hum. Mol. Genet. 2013;22:2676&#x2013;2688. doi: 10.1093/hmg/ddt117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt117</ArticleId><ArticleId IdType="pmc">PMC3674807</ArticleId><ArticleId IdType="pubmed">23474818</ArticleId></ArticleIdList></Reference><Reference><Citation>Azuma Y., Tokuda T., Kushimura Y., Yamamoto I., Mizuta I., Mizuno T., Nakagawa M., Ueyama M., Nagai Y., Iwasaki Y., et al. Hippo, Drosophila MST, is a novel modifier of motor neuron degeneration induced by knockdown of Caz, Drosophila FUS. Exp. Cell Res. 2018;371:311&#x2013;321. doi: 10.1016/j.yexcr.2018.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2018.08.001</ArticleId><ArticleId IdType="pubmed">30092221</ArticleId></ArticleIdList></Reference><Reference><Citation>Gogia N., Sarkar A., Mehta A.S., Ramesh N., Deshpande P., Kango-Singh M., Pandey U.B., Singh A. Inactivation of Hippo and cJun-N-terminal Kinase (JNK) signaling mitigate FUS mediated neurodegeneration in vivo. Neurobiol. Dis. 2020;140:104837. doi: 10.1016/j.nbd.2020.104837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104837</ArticleId><ArticleId IdType="pubmed">32199908</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes P.S., Daniel S.G., McCallum A.P., Boehringer A.V., Sukhina A.S., Zwick R.A., Zarnescu D.C. Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a Drosophila model of amyotrophic lateral sclerosis. Dis. Model. Mech. 2013;6:721&#x2013;733. doi: 10.1242/dmm.010710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.010710</ArticleId><ArticleId IdType="pmc">PMC3634655</ArticleId><ArticleId IdType="pubmed">23471911</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes P.S., Boehringer A., Zwick R., Tang J.E., Grigsby B., Zarnescu D.C. Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Hum. Mol. Genet. 2011;20:2308&#x2013;2321. doi: 10.1093/hmg/ddr124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr124</ArticleId><ArticleId IdType="pmc">PMC3098735</ArticleId><ArticleId IdType="pubmed">21441568</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson K.A., Kim S.H., Wassarman D.A., Tibbetts R.S. Ubiquilin Modifies TDP-43 Toxicity in a Drosophila Model of Amyotrophic Lateral Sclerosis (ALS) J. Biol. Chem. 2010;285:11068&#x2013;11072. doi: 10.1074/jbc.C109.078527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C109.078527</ArticleId><ArticleId IdType="pmc">PMC2856981</ArticleId><ArticleId IdType="pubmed">20154090</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Ray P., Rao E.J., Shi C., Guo W., Chen X., Woodruff E.A., Fushimi K., Wu J.Y. A Drosophila model for TDP-43 proteinopathy. Proc. Natl. Acad. Sci. USA. 2010;107:3169&#x2013;3174. doi: 10.1073/pnas.0913602107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0913602107</ArticleId><ArticleId IdType="pmc">PMC2840283</ArticleId><ArticleId IdType="pubmed">20133767</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaper D.C., Adachi Y., Lazarou L., Greenstein M., Simoes F.A., Di Domenico A., Solomon D.A., Lowe S., Alsubaie R., Cheng D., et al. Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD. Hum. Mol. Genet. 2013;22:3883&#x2013;3893. doi: 10.1093/hmg/ddt243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt243</ArticleId><ArticleId IdType="pmc">PMC3766182</ArticleId><ArticleId IdType="pubmed">23727833</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M.-J., Cheng C.-W., Shen C.-K.J. Neuronal Function and Dysfunction of Drosophila dTDP. PLoS ONE. 2011;6:e20371. doi: 10.1371/journal.pone.0020371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020371</ArticleId><ArticleId IdType="pmc">PMC3105987</ArticleId><ArticleId IdType="pubmed">21673800</ArticleId></ArticleIdList></Reference><Reference><Citation>Langellotti S., Romano V., Romano G., Klima R., Feiguin F., Cragnaz L., Romano M., Baralle F.E. A novel Drosophila model of TDP-43 proteinopathies: N-terminal sequences combined with the Q/N domain induce protein functional loss and locomotion defects. Dis. Model. Mech. 2016;9:659&#x2013;669. doi: 10.1242/dmm.023382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.023382</ArticleId><ArticleId IdType="pmc">PMC4920146</ArticleId><ArticleId IdType="pubmed">27101846</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiguin F., Godena V.K., Romano G., D&#x2019;Ambrogio A., Klima R., Baralle F.E. Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett. 2009;583:1586&#x2013;1592. doi: 10.1016/j.febslet.2009.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2009.04.019</ArticleId><ArticleId IdType="pubmed">19379745</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies F.M., Fleming A., Caricasole A., Bento C.F., Andrews S.P., Ashkenazi A., F&#xfc;llgrabe J., Jackson A., Sanchez M.J., Karabiyik C., et al. Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities. Neuron. 2017;93:1015&#x2013;1034. doi: 10.1016/j.neuron.2017.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.01.022</ArticleId><ArticleId IdType="pubmed">28279350</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng C.-W., Lin M.-J., Shen C.-K.J. Rapamycin alleviates pathogenesis of a new Drosophila model of ALS-TDP. J. Neurogenetics. 2015;29:59&#x2013;68. doi: 10.3109/01677063.2015.1077832.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01677063.2015.1077832</ArticleId><ArticleId IdType="pubmed">26219309</ArticleId></ArticleIdList></Reference><Reference><Citation>Donde A., Sun M., Jeong Y.H., Wen X., Ling J., Lin S., Braunstein K., Nie S., Wang S., Chen L., et al. Upregulation of ATG7 attenuates motor neuron dysfunction associated with depletion of TARDBP/TDP-43. Autophagy. 2020;16:672&#x2013;682. doi: 10.1080/15548627.2019.1635379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1635379</ArticleId><ArticleId IdType="pmc">PMC7138241</ArticleId><ArticleId IdType="pubmed">31242080</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Duan Y., Qin C., Li J.-C., Duan G., Deng X., Ni J., Cao X., Xiang K., Tian K., et al. Distinct multilevel misregulations of Parkin and PINK1 revealed in cell and animal models of TDP-43 proteinopathy. Cell Death Dis. 2018;9:1&#x2013;16. doi: 10.1038/s41419-018-1022-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-1022-y</ArticleId><ArticleId IdType="pmc">PMC6148241</ArticleId><ArticleId IdType="pubmed">30237395</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil B., Cabirol-Pol M.-J., Miguel L., Whitworth A.J., Lecourtois M., Li&#xe9;vens J.-C. Enhancing Mitofusin/Marf ameliorates neuromuscular dysfunction in Drosophila models of TDP-43 proteinopathies. Neurobiol. Aging. 2017;54:71&#x2013;83. doi: 10.1016/j.neurobiolaging.2017.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.02.016</ArticleId><ArticleId IdType="pubmed">28324764</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo E., Lorenzini I., Barrameda D., O&#x2019;Conner A.G., Barrows J.M., Starr A., Kovalik T., Rabichow B.E., Lehmkuhl E.M., Shreiner D.D., et al. Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. eLife. 2019;8 doi: 10.7554/eLife.45114.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.45114</ArticleId><ArticleId IdType="pmc">PMC6557627</ArticleId><ArticleId IdType="pubmed">31180318</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo E., O&#x2019;Conner A.G., Barrows J.M., Shreiner D.D., Birchak G.J., Zarnescu D.C. Medium-Chain Fatty Acids, Beta-Hydroxybutyric Acid and Genetic Modulation of the Carnitine Shuttle Are Protective in a Drosophila Model of ALS Based on TDP-43. Front. Mol. Neurosci. 2018;11:182. doi: 10.3389/fnmol.2018.00182.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00182</ArticleId><ArticleId IdType="pmc">PMC5990617</ArticleId><ArticleId IdType="pubmed">29904341</ArticleId></ArticleIdList></Reference><Reference><Citation>Joardar A., Manzo E., Zarnescu D.C. Metabolic Dysregulation in Amyotrophic Lateral Sclerosis: Challenges and Opportunities. Curr. Genet. Med. Rep. 2017;5:108&#x2013;114. doi: 10.1007/s40142-017-0123-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40142-017-0123-8</ArticleId><ArticleId IdType="pmc">PMC5647833</ArticleId><ArticleId IdType="pubmed">29057168</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne A.N., Siddegowda B.B., Estes P.S., Johannesmeyer J., Kovalik T., Daniel S.G., Pearson A., Bowser R., Zarnescu D.C. Futsch/MAP1B mRNA Is a Translational Target of TDP-43 and Is Neuroprotective in a Drosophila Model of Amyotrophic Lateral Sclerosis. J. Neurosci. 2014;34:15962&#x2013;15974. doi: 10.1523/JNEUROSCI.2526-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2526-14.2014</ArticleId><ArticleId IdType="pmc">PMC4244467</ArticleId><ArticleId IdType="pubmed">25429138</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Y., Du A., Gu J., Duan G., Wang C., Gui X., Ma Z., Qian B., Deng X., Zhang K., et al. PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins. Cell Res. 2019;29:233&#x2013;247. doi: 10.1038/s41422-019-0141-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-019-0141-z</ArticleId><ArticleId IdType="pmc">PMC6460439</ArticleId><ArticleId IdType="pubmed">30728452</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L., Gomes E., Guo L., Mojsilovic-Petrovic J., Tran V., Kalb R.G., Shorter J., Bonini N.M. Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization. Mol. Cell. 2018;71:703&#x2013;717. doi: 10.1016/j.molcel.2018.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.07.002</ArticleId><ArticleId IdType="pmc">PMC6128762</ArticleId><ArticleId IdType="pubmed">30100264</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsukawa K., Kukharsky M.S., Park S.-K., Park S., Watanabe N., Iwatsubo T., Hashimoto T., Liebman S.W., Shelkovnikova T.A. Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy. RNA Biol. 2021:1&#x2013;9. doi: 10.1080/15476286.2020.1860580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2020.1860580</ArticleId><ArticleId IdType="pubmed">33427561</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Lu Y., Lopez-Gonzalez R., Kim N.C., Almeida S., Lee K.-H., Badders N., Valentine M., Miller B.L., Wong P.C., et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nat. Cell Biol. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S., Gr&#xf6;nke S., Niccoli T., Ridler C.E., Clayton E.L., Devoy A., Moens T., Norona F.E., Woollacott I.O.C., Pietrzyk J., et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science. 2014;345:1192&#x2013;1194. doi: 10.1126/science.1256800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Poidevin M., Li X., Li Y., Shu L., Nelson D.L., Li H., Hales C.M., Gearing M., Wingo T.S., et al. Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc. Natl. Acad. Sci. USA. 2013;110:7778&#x2013;7783. doi: 10.1073/pnas.1219643110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1219643110</ArticleId><ArticleId IdType="pmc">PMC3651485</ArticleId><ArticleId IdType="pubmed">23553836</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman L.D., Prudencio M., Kramer N.J., Martinez-Ramirez L.F., Srinivasan A.R., Lan M., Parisi M.J., Zhu Y., Chew J., Cook C.N., et al. Toxic expanded GGGGCC repeat transcription is mediated by the PAF1 complex in C9orf72-associated FTD. Nat. Neurosci. 2019;22:863&#x2013;874. doi: 10.1038/s41593-019-0396-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0396-1</ArticleId><ArticleId IdType="pmc">PMC6535128</ArticleId><ArticleId IdType="pubmed">31110321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer N.J., Carlomagno Y., Zhang Y.-J., Almeida S., Cook C.N., Gendron T.F., Prudencio M., Van Blitterswijk M., Belzil V., Couthouis J., et al. Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts. Science. 2016;353:708&#x2013;712. doi: 10.1126/science.aaf7791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf7791</ArticleId><ArticleId IdType="pmc">PMC5823025</ArticleId><ArticleId IdType="pubmed">27516603</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman L.D., Bonini N.M. New Roles for Canonical Transcription Factors in Repeat Expansion Diseases. Trends Genet. 2020;36:81&#x2013;92. doi: 10.1016/j.tig.2019.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2019.11.003</ArticleId><ArticleId IdType="pmc">PMC6980727</ArticleId><ArticleId IdType="pubmed">31837826</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirtreiter A., Damsma G.E., Cheung A.C.M., Klose D., Grohmann D., Vojnic E., Martin A.C.R., Cramer P., Werner F. Spt4/5 stimulates transcription elongation through the RNA polymerase clamp coiled-coil motif. Nucleic Acids Res. 2010;38:4040&#x2013;4051. doi: 10.1093/nar/gkq135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq135</ArticleId><ArticleId IdType="pmc">PMC2896526</ArticleId><ArticleId IdType="pubmed">20197319</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman L.D., Prudencio M., Srinivasan A.R., Rifai O.M., Lee V.M.-Y., Petrucelli L., Bonini N.M. eIF4B and eIF4H mediate GR production from expanded G4C2 in a Drosophila model for C9orf72-associated ALS. Acta Neuropathol. Commun. 2019;7:1&#x2013;16. doi: 10.1186/s40478-019-0711-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0711-9</ArticleId><ArticleId IdType="pmc">PMC6485101</ArticleId><ArticleId IdType="pubmed">31023341</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Donnelly C.J., Haeusler A.R., Grima J.C., Machamer J.B., Steinwald P., Daley E.L., Miller S.J., Cunningham K.M., Vidensky S., et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nat. Cell Biol. 2015;525:56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham K.M., Maulding K., Ruan K., Senturk M., Grima J.C., Sung H., Zuo Z., Song H., Gao J., Dubey S., et al. TFEB/Mitf links impaired nuclear import to autophagolysosomal dysfunction in C9-ALS. eLife. 2020;9 doi: 10.7554/eLife.59419.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.59419</ArticleId><ArticleId IdType="pmc">PMC7758070</ArticleId><ArticleId IdType="pubmed">33300868</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Bogaert E., Michiels E., Gijselinck I., Sieben A., Jovi&#x10d;i&#x107; A., De Baets G., Scheveneels W., Steyaert J., Cuijt I., et al. Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Sci. Rep. 2016;6:20877. doi: 10.1038/srep20877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20877</ArticleId><ArticleId IdType="pmc">PMC4751451</ArticleId><ArticleId IdType="pubmed">26869068</ArticleId></ArticleIdList></Reference><Reference><Citation>Azoulay-Ginsburg S., Di Salvio M., Weitman M., Afri M., Ribeiro S., Ebbinghaus S., Cestra G., Gruzman A. Chemical chaperones targeted to the endoplasmic reticulum (ER) and lysosome prevented neurodegeneration in a C9orf72 repeat expansion drosophila amyotrophic lateral sclerosis (ALS) model. Pharmacol. Rep. 2021;73:536&#x2013;550. doi: 10.1007/s43440-021-00226-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43440-021-00226-2</ArticleId><ArticleId IdType="pubmed">33661518</ArticleId></ArticleIdList></Reference><Reference><Citation>Babin P.J., Goizet C., Rald&#xfa;a D. Zebrafish models of human motor neuron diseases: Advantages and limitations. Prog. Neurobiol. 2014;118:36&#x2013;58. doi: 10.1016/j.pneurobio.2014.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2014.03.001</ArticleId><ArticleId IdType="pubmed">24705136</ArticleId></ArticleIdList></Reference><Reference><Citation>Abugable A.A., Morris J.L., Palminha N.M., Zaksauskaite R., Ray S., El-Khamisy S.F. DNA repair and neurological disease: From molecular understanding to the development of diagnostics and model organisms. DNA Repair. 2019;81:102669. doi: 10.1016/j.dnarep.2019.102669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2019.102669</ArticleId><ArticleId IdType="pubmed">31331820</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw C.A., Morrice J.R., Gregory-Evans C.Y. Animal models of amyotrophic lateral sclerosis: A comparison of model validity. Neural Regen. Res. 2018;13:2050&#x2013;2054. doi: 10.4103/1673-5374.241445.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.241445</ArticleId><ArticleId IdType="pmc">PMC6199948</ArticleId><ArticleId IdType="pubmed">30323119</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh T., Lyon A.N., Pineda R.H., Wang C., Janssen P.M.L., Canan B.D., Burghes A.H.M., Beattie C.E. A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease. Dis. Model. Mech. 2010;3:652&#x2013;662. doi: 10.1242/dmm.005538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.005538</ArticleId><ArticleId IdType="pmc">PMC2931540</ArticleId><ArticleId IdType="pubmed">20504969</ArticleId></ArticleIdList></Reference><Reference><Citation>Parakh S., Shadfar S., Perri E.R., Ragagnin A.M., Piattoni C.V., Fogol&#xed;n M.B., Yuan K.C., Shahheydari H., Don E.K., Thomas C.J., et al. The Redox Activity of Protein Disulfide Isomerase Inhibits ALS Phenotypes in Cellular and Zebrafish Models. iScience. 2020;23:101097. doi: 10.1016/j.isci.2020.101097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101097</ArticleId><ArticleId IdType="pmc">PMC7240177</ArticleId><ArticleId IdType="pubmed">32446203</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Bercier V., Lissouba A., Liao M., Brustein E., Rouleau G.A., Drapeau P. FUS and TARDBP but Not SOD1 Interact in Genetic Models of Amyotrophic Lateral Sclerosis. PLoS Genet. 2011;7:e1002214. doi: 10.1371/journal.pgen.1002214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002214</ArticleId><ArticleId IdType="pmc">PMC3150442</ArticleId><ArticleId IdType="pubmed">21829392</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Lin L., Tradewell M.L., Dion P.A., Bercier V., Bourgouin P., Rochefort D., Hadj S.B., Durham H.D., Velde C.V., et al. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum. Mol. Genet. 2009;19:671&#x2013;683. doi: 10.1093/hmg/ddp534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp534</ArticleId><ArticleId IdType="pubmed">19959528</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanari M.-L., Marian A., Ciura S., Kabashi E. TDP-43 Regulation of AChE Expression Can Mediate ALS-Like Phenotype in Zebrafish. Cells. 2021;10:221. doi: 10.3390/cells10020221.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020221</ArticleId><ArticleId IdType="pmc">PMC7911940</ArticleId><ArticleId IdType="pubmed">33499374</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciura S., Lattante S., Le Ber I., Latouche M., Tostivint H., Brice A., Kabashi E. Loss of function of C9orf72 causes motor deficits in a zebrafish model of Amyotrophic Lateral Sclerosis. Ann. Neurol. 2013;74:180&#x2013;187. doi: 10.1002/ana.23946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23946</ArticleId><ArticleId IdType="pubmed">23720273</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortier G., Butti Z., Patten S.A. Modelling C9orf72-Related Amyotrophic Lateral Sclerosis in Zebrafish. Biomedicines. 2020;8:440. doi: 10.3390/biomedicines8100440.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8100440</ArticleId><ArticleId IdType="pmc">PMC7589578</ArticleId><ArticleId IdType="pubmed">33096681</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.-B., Chen H.-J., Peres J.N., Gomez-Deza J., Attig J., &#x160;talekar M., Troakes C., Nishimura A.L., Scotter E.L., Vance C., et al. Hexanucleotide Repeats in ALS/FTD Form Length-Dependent RNA Foci, Sequester RNA Binding Proteins, and Are Neurotoxic. Cell Rep. 2013;5:1178&#x2013;1186. doi: 10.1016/j.celrep.2013.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.10.049</ArticleId><ArticleId IdType="pmc">PMC3898469</ArticleId><ArticleId IdType="pubmed">24290757</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Bento-Abreu A., Gendron T.F., Boeynaems S., Bogaert E., Nuyts R., Timmers M., Scheveneels W., Hersmus N., Wang J., et al. A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism. Acta Neuropathol. 2018;135:427&#x2013;443. doi: 10.1007/s00401-017-1796-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1796-5</ArticleId><ArticleId IdType="pubmed">29302778</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw M.P., Higginbottom A., McGown A., Castelli L.M., James E., Hautbergue G.M., Shaw P.J., Ramesh T.M. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features. Acta Neuropathol. Commun. 2018;6:125. doi: 10.1186/s40478-018-0629-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0629-7</ArticleId><ArticleId IdType="pmc">PMC6240957</ArticleId><ArticleId IdType="pubmed">30454072</ArticleId></ArticleIdList></Reference><Reference><Citation>De Giorgio F., Maduro C., Fisher E.M.C., Acevedo-Arozena A. Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis. Dis. Model. Mech. 2019;12:dmm037424. doi: 10.1242/dmm.037424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.037424</ArticleId><ArticleId IdType="pmc">PMC6361152</ArticleId><ArticleId IdType="pubmed">30626575</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Sosa M.A.G., De Gasperi R., Elder G.A. Modeling human neurodegenerative diseases in transgenic systems. Qual. Life Res. 2011;131:535&#x2013;563. doi: 10.1007/s00439-011-1119-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-011-1119-1</ArticleId><ArticleId IdType="pubmed">22167414</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E., Okawa E., Watanabe S., Ono S.-I., Marklund S.L. Dysregulation of intracellular copper homeostasis is common to transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper-binding abilities. Neurobiol. Dis. 2013;54:308&#x2013;319. doi: 10.1016/j.nbd.2013.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.01.001</ArticleId><ArticleId IdType="pubmed">23321002</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S., Caputi F., Pignataro A., Amadio S., Fabbrizio P., Ammassari-Teule M., Volont&#xe9; C. Histamine Is an Inducer of the Heat Shock Response in SOD1-G93A Models of ALS. Int. J. Mol. Sci. 2019;20:3793. doi: 10.3390/ijms20153793.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20153793</ArticleId><ArticleId IdType="pmc">PMC6696457</ArticleId><ArticleId IdType="pubmed">31382568</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S., Amadio S., Fabbrizio P., Morello G., Spampinato A.G., Latagliata E.C., Salvatori I., Proietti D., Ferri A., Madaro L., et al. Histaminergic transmission slows progression of amyotrophic lateral sclerosis. J. Cachex Sarcopenia Muscle. 2019;10:872&#x2013;893. doi: 10.1002/jcsm.12422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12422</ArticleId><ArticleId IdType="pmc">PMC6711424</ArticleId><ArticleId IdType="pubmed">31020811</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbrizio P., Apolloni S., Bianchi A., Salvatori I., Valle C., Lanzuolo C., Bendotti C., Nardo G., Volont&#xe9; C. P2X7 activation enhances skeletal muscle metabolism and regeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis. Brain Pathol. 2019;30:272&#x2013;282. doi: 10.1111/bpa.12774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12774</ArticleId><ArticleId IdType="pmc">PMC7065186</ArticleId><ArticleId IdType="pubmed">31376190</ArticleId></ArticleIdList></Reference><Reference><Citation>Volont&#xe9; C., Amadio S., Fabbrizio P., Apolloni S. Functional microglia neurotransmitters in amyotrophic lateral sclerosis. Semin. Cell Dev. Biol. 2019;94:121&#x2013;128. doi: 10.1016/j.semcdb.2019.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.04.014</ArticleId><ArticleId IdType="pubmed">31009755</ArticleId></ArticleIdList></Reference><Reference><Citation>Proietti D., Giordani L., De Bardi M., D&#x2019;Ercole C., Lozanoska-Ochser B., Amadio S., Volont&#xe8; C., Marinelli S., Muchir A., Bouch&#xe8; M., et al. Activation of skeletal muscle-resident glial cells upon nerve injury. JCI Insight. 2021 doi: 10.1172/jci.insight.143469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.143469</ArticleId><ArticleId IdType="pubmed">33661767</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepore E., Casola I., Dobrowolny G., Musar&#xf2; A. Neuromuscular Junction as an Entity of Nerve-Muscle Communication. Cells. 2019;8:906. doi: 10.3390/cells8080906.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8080906</ArticleId><ArticleId IdType="pmc">PMC6721719</ArticleId><ArticleId IdType="pubmed">31426366</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J., Kang Y., Zhou Y., Li X., Lan J., Wu L., Feng X., Peng Y. ALS-causing SOD1 mutants regulate occludin phosphorylation/ubiquitination and endocytic trafficking via the ITCH/Eps15/Rab5 axis. Neurobiol. Dis. 2021;153:105315. doi: 10.1016/j.nbd.2021.105315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2021.105315</ArticleId><ArticleId IdType="pubmed">33636390</ArticleId></ArticleIdList></Reference><Reference><Citation>Alrafiah A. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis. Vivo. 2018;32:983&#x2013;998. doi: 10.21873/invivo.11339.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/invivo.11339</ArticleId><ArticleId IdType="pmc">PMC6199613</ArticleId><ArticleId IdType="pubmed">30150420</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J., Comley L.H., Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty M.J., Mu E.W.H., Noakes P.G., Lavidis N.A., Bellingham M.C. Marked changes in dendritic structure and spine density precede significant neuronal death in vulnerable cortical pyramidal neuron populations in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2016;4:1&#x2013;21. doi: 10.1186/s40478-016-0347-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0347-y</ArticleId><ArticleId IdType="pmc">PMC4973034</ArticleId><ArticleId IdType="pubmed">27488828</ArticleId></ArticleIdList></Reference><Reference><Citation>Saba L., Viscomi M.T., Caioli S., Pignataro A., Bisicchia E., Pieri M., Molinari M., Ammassari-Teule M., Zona C. Altered Functionality, Morphology, and Vesicular Glutamate Transporter Expression of Cortical Motor Neurons from a Presymptomatic Mouse Model of Amyotrophic Lateral Sclerosis. Cereb. Cortex. 2016;26:1512&#x2013;1528. doi: 10.1093/cercor/bhu317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhu317</ArticleId><ArticleId IdType="pubmed">25596588</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce P.I., McGoldrick P., Saccon R.A., Weber W., Fratta P., West S.J., Zhu N., Carter S., Phatak V., Stewart M., et al. A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity. Hum. Mol. Genet. 2015;24:1883&#x2013;1897. doi: 10.1093/hmg/ddu605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu605</ArticleId><ArticleId IdType="pmc">PMC4355022</ArticleId><ArticleId IdType="pubmed">25468678</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson P.A., Graffmo K.S., Br&#xe4;nnstr&#xf6;m T., Nilsson M.P., Andersen P.M., Marklund S.L. Motor Neuron Disease in Mice Expressing the Wild Type-Like D90A Mutant Superoxide Dismutase-1. J. Neuropathol. Exp. Neurol. 2006;65:1126&#x2013;1136. doi: 10.1097/01.jnen.0000248545.36046.3c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000248545.36046.3c</ArticleId><ArticleId IdType="pubmed">17146286</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Cleveland D.W., Price D.L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 1995;14:1105&#x2013;1116. doi: 10.1016/0896-6273(95)90259-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90259-7</ArticleId><ArticleId IdType="pubmed">7605627</ArticleId></ArticleIdList></Reference><Reference><Citation>Magota H., Sasaki M., Kataoka-Sasaki Y., Oka S., Ukai R., Kiyose R., Onodera R., Kocsis J.D., Honmou O. Intravenous infusion of mesenchymal stem cells delays disease progression in the SOD1G93A transgenic amyotrophic lateral sclerosis rat model. Brain Res. 2021;1757:147296. doi: 10.1016/j.brainres.2021.147296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2021.147296</ArticleId><ArticleId IdType="pubmed">33516815</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair I.P., Williams K.L., Warraich S.T., Durnall J.C., Thoeng A.D., Manavis J., Blumbergs P.C., Vucic S., Kiernan M.C., Nicholson G.A. FUS mutations in amyotrophic lateral sclerosis: Clinical, pathological, neurophysiological and genetic analysis. J. Neurol. Neurosurg. Psychiatry. 2009;81:639&#x2013;645. doi: 10.1136/jnnp.2009.194399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.194399</ArticleId><ArticleId IdType="pubmed">19965854</ArticleId></ArticleIdList></Reference><Reference><Citation>Gois A.M., Mendon&#xe7;a D.M., Freire M.A.M., Santos J.R. In Vitro And In Vivo Models of Amyotrophic Lateral Sclerosis: An Updated Overview. Brain Res. Bull. 2020;159:32&#x2013;43. doi: 10.1016/j.brainresbull.2020.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2020.03.012</ArticleId><ArticleId IdType="pubmed">32247802</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.-C., Dastidar S.G., Tokunaga S., Ho W.Y., Lim K., Ilieva H., Parone P.A., Tyan S.-H., Tse T.M., Chang J.-C., et al. Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axis. eLife. 2019;8 doi: 10.7554/eLife.40811.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.40811</ArticleId><ArticleId IdType="pmc">PMC6389288</ArticleId><ArticleId IdType="pubmed">30747709</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishigaki S., Fujioka Y., Okada Y., Riku Y., Udagawa T., Honda D., Yokoi S., Endo K., Ikenaka K., Takagi S., et al. Altered Tau Isoform Ratio Caused by Loss of FUS and SFPQ Function Leads to FTLD-like Phenotypes. Cell Rep. 2017;18:1118&#x2013;1131. doi: 10.1016/j.celrep.2017.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.01.013</ArticleId><ArticleId IdType="pubmed">28147269</ArticleId></ArticleIdList></Reference><Reference><Citation>Udagawa T., Fujioka Y., Tanaka M., Honda D., Yokoi S., Riku Y., Ibi D., Nagai T., Yamada K., Watanabe H., et al. FUS regulates AMPA receptor function and FTLD/ALS-associated behaviour via GluA1 mRNA stabilization. Nat. Commun. 2015;6:7098. doi: 10.1038/ncomms8098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8098</ArticleId><ArticleId IdType="pmc">PMC4479014</ArticleId><ArticleId IdType="pubmed">25968143</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin V.M., Leverenz J.B., Bekris L.M., Bird T.D., Yuan W., Elman L.B., Clay D., Wood E.M., Chen-Plotkin A.S., Martinez-Lage M., et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: A genetic and histopathological analysis. Lancet Neurol. 2008;7:409&#x2013;416. doi: 10.1016/S1474-4422(08)70071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70071-1</ArticleId><ArticleId IdType="pmc">PMC3546119</ArticleId><ArticleId IdType="pubmed">18396105</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Konopka A., Whelan D.R., Jamali S., Perri E., Shahheydari H., Toth R.P., Parakh S., Robinson T., Cheong A., Mehta P., et al. Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations. Mol. Neurodegener. 2020;15:1&#x2013;28. doi: 10.1186/s13024-020-00386-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00386-4</ArticleId><ArticleId IdType="pmc">PMC7488163</ArticleId><ArticleId IdType="pubmed">32907630</ArticleId></ArticleIdList></Reference><Reference><Citation>Riemslagh F.W., van der Toorn E.C., Verhagen R.F.M., Maas A., Bosman L.W.J., Hukema R.K., Willemsen R. Inducible expression of human C9ORF72 36 &#xd7; G4C2 hexanucleotide repeats is sufficient to cause RAN translation and rapid muscular atrophy in mice. Dis. Model. Mech. 2021;14:dmm044842. doi: 10.1242/dmm.044842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.044842</ArticleId><ArticleId IdType="pmc">PMC7903916</ArticleId><ArticleId IdType="pubmed">33431483</ArticleId></ArticleIdList></Reference><Reference><Citation>Herranz-Martin S., Chandran J., Lewis K., Mulcahy P., Higginbottom A., Walker C., Valenzuela I.M.-P.Y., Jones R.A., Coldicott I., Iannitti T., et al. Viral delivery of C9orf72 hexanucleotide repeat expansions in mice leads to repeat-length-dependent neuropathology and behavioural deficits. Dis. Model. Mech. 2017;10:859&#x2013;868. doi: 10.1242/dmm.029892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.029892</ArticleId><ArticleId IdType="pmc">PMC5536911</ArticleId><ArticleId IdType="pubmed">28550099</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J., Gendron T.F., Prudencio M., Sasaguri H., Zhang Y.-J., Castanedes-Casey M., Lee C.W., Jansen-West K., Kurti A., Murray M.E., et al. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science. 2015;348:1151&#x2013;1154. doi: 10.1126/science.aaa9344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa9344</ArticleId><ArticleId IdType="pmc">PMC4692360</ArticleId><ArticleId IdType="pubmed">25977373</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi M.H., Becker L., Garrett L., Gendron T.F., Zhou Q., Schreiber F., Popper B., Dimou L., Strom T.M., Winkelmann J., et al. Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss. Acta Neuropathol. 2017;134:241&#x2013;254. doi: 10.1007/s00401-017-1711-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1711-0</ArticleId><ArticleId IdType="pmc">PMC5508040</ArticleId><ArticleId IdType="pubmed">28409281</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Pattamatta A., Zu T., Reid T., Bardhi O., Borchelt D.R., Yachnis A.T., Ranum L.P. C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD. Neuron. 2016;90:521&#x2013;534. doi: 10.1016/j.neuron.2016.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers M., Blokhuis A.M., Westeneng H., Terpstra M.L., Zundel C.A.C., De S&#xe1; R.V., Schellevis R.D., Waite A.J., Blake D.J., Veldink J.H., et al. C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Ann. Neurol. 2015;78:426&#x2013;438. doi: 10.1002/ana.24453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24453</ArticleId><ArticleId IdType="pmc">PMC4744979</ArticleId><ArticleId IdType="pubmed">26044557</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong W., Zhang L., Sun C., Gao X., Guan F., Li J., Chen W., Ma Y., Zhang L. Knock in of a hexanucleotide repeat expansion in the C9orf72 gene induces ALS in rats. Anim. Model. Exp. Med. 2020;3:237&#x2013;244. doi: 10.1002/ame2.12129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ame2.12129</ArticleId><ArticleId IdType="pmc">PMC7529333</ArticleId><ArticleId IdType="pubmed">33024945</ArticleId></ArticleIdList></Reference><Reference><Citation>Jager W.D.H. Experimental amyotrophic lateral sclerosis in the Guinea-Pig. J. Neurol. Sci. 1985;67:133&#x2013;142. doi: 10.1016/0022-510X(85)90110-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(85)90110-8</ArticleId><ArticleId IdType="pubmed">3981216</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R., Engelhardt J.I., Tajti J., Appel S.H. Experimental immune-mediated motor neuron diseases: Models for human ALS. Brain Res. Bull. 1993;30:373&#x2013;380. doi: 10.1016/0361-9230(93)90268-G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0361-9230(93)90268-G</ArticleId><ArticleId IdType="pubmed">8457886</ArticleId></ArticleIdList></Reference><Reference><Citation>Appel S.H., Engelhardt J.I., Garcia J., Stefani E. Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction. Proc. Natl. Acad. Sci. USA. 1991;88:647&#x2013;651. doi: 10.1073/pnas.88.2.647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.88.2.647</ArticleId><ArticleId IdType="pmc">PMC50869</ArticleId><ArticleId IdType="pubmed">1988960</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt J.I., Sikl&#xf3;s L., Appel S.H. Altered Calcium Homeostasis and Ultrastructure in Motoneurons of Mice Caused by Passively Transferred Anti-motoneuronal IgG. J. Neuropathol. Exp. Neurol. 1997;56:21&#x2013;39. doi: 10.1097/00005072-199701000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199701000-00003</ArticleId><ArticleId IdType="pubmed">8990126</ArticleId></ArticleIdList></Reference><Reference><Citation>Ob&#xe1;l I., N&#xf3;gr&#xe1;di B., Meszl&#xe9;nyi V., Patai R., Ricken G., Kovacs G.G., Tripolszki K., Sz&#xe9;ll M., Sikl&#xf3;s L., Engelhardt J.I. Experimental Motor Neuron Disease Induced in Mice with Long-Term Repeated Intraperitoneal Injections of Serum from ALS Patients. Int. J. Mol. Sci. 2019;20:2573. doi: 10.3390/ijms20102573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20102573</ArticleId><ArticleId IdType="pmc">PMC6566871</ArticleId><ArticleId IdType="pubmed">31130623</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardone R., H&#xf6;ller Y., Taylor A.C., Lochner P., Tezzon F., Golaszewski S., Brigo F., Trinka E. Canine degenerative myelopathy: A model of human amyotrophic lateral sclerosis. Zoology. 2016;119:64&#x2013;73. doi: 10.1016/j.zool.2015.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.zool.2015.09.003</ArticleId><ArticleId IdType="pubmed">26432396</ArticleId></ArticleIdList></Reference><Reference><Citation>Awano T., Johnson G.S., Wade C.M., Katz M.L., Johnson G.C., Taylor J.F., Perloski M., Biagi T., Baranowska I., Long S., et al. Genome-wide association analysis reveals aSOD1mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2009;106:2794&#x2013;2799. doi: 10.1073/pnas.0812297106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0812297106</ArticleId><ArticleId IdType="pmc">PMC2634802</ArticleId><ArticleId IdType="pubmed">19188595</ArticleId></ArticleIdList></Reference><Reference><Citation>Golubczyk D., Malysz-Cymborska I., Kalkowski L., Janowski M., Coates J.R., Wojtkiewicz J., Maksymowicz W., Walczak P. The Role of Glia in Canine Degenerative Myelopathy: Relevance to Human Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2019;56:5740&#x2013;5748. doi: 10.1007/s12035-019-1488-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1488-3</ArticleId><ArticleId IdType="pmc">PMC6614142</ArticleId><ArticleId IdType="pubmed">30674036</ArticleId></ArticleIdList></Reference><Reference><Citation>Wininger F., Zeng R., Johnson G., Katz M., Johnson G., Bush W., Jarboe J., Coates J. Degenerative Myelopathy in a Bernese Mountain Dog with a Novel SOD1 Missense Mutation. J. Veter. Intern. Med. 2011;25:1166&#x2013;1170. doi: 10.1111/j.1939-1676.2011.0760.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1939-1676.2011.0760.x</ArticleId><ArticleId IdType="pubmed">21848967</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisp M.J., Beckett J., Coates J.R., Miller T.M. Canine degenerative myelopathy: Biochemical characterization of superoxide dismutase 1 in the first naturally occurring non-human amyotrophic lateral sclerosis model. Exp. Neurol. 2013;248:1&#x2013;9. doi: 10.1016/j.expneurol.2013.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2013.05.009</ArticleId><ArticleId IdType="pmc">PMC3773294</ArticleId><ArticleId IdType="pubmed">23707216</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura S., Kamatari Y.O., Kuwahara Y., Hara H., Yamato O., Maeda S., Kamishina H., Honda R. Canine SOD1 harboring E40K or T18S mutations promotes protein aggregation without reducing the global structural stability. PeerJ. 2020;8:e9512. doi: 10.7717/peerj.9512.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.9512</ArticleId><ArticleId IdType="pmc">PMC7368427</ArticleId><ArticleId IdType="pubmed">32742795</ArticleId></ArticleIdList></Reference><Reference><Citation>Toedebusch C.M., Snyder J.C., Jones M.R., Garcia V.B., Johnson G.C., Villal&#xf3;n E.L., Coates J.R., Garcia M.L. Arginase-1 expressing microglia in close proximity to motor neurons were increased early in disease progression in canine degenerative myelopathy, a model of amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 2018;88:148&#x2013;157. doi: 10.1016/j.mcn.2018.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2018.01.009</ArticleId><ArticleId IdType="pubmed">29408267</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Trapero M., Espejo-Porras F., Rodr&#xed;guez-Cueto C., Coates J.R., P&#xe9;rez-D&#xed;az C., De Lago E., Fern&#xe1;ndez-Ruiz J. Upregulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis. Dis. Model. Mech. 2017;10:551&#x2013;558. doi: 10.1242/dmm.028373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.028373</ArticleId><ArticleId IdType="pmc">PMC5451172</ArticleId><ArticleId IdType="pubmed">28069688</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis K.E., Rasmussen A.L., Bennett W., King A., West A.K., Chung R.S., Chuah M.I. Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: Changes in arginase1 and inducible nitric oxide synthase. J. Neuroinflammation. 2014;11:55. doi: 10.1186/1742-2094-11-55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-55</ArticleId><ArticleId IdType="pmc">PMC3994340</ArticleId><ArticleId IdType="pubmed">24655927</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Morrison B.M., Li Y., Lengacher S., Farah M.H., Hoffman P.N., Liu Y., Tsingalia A., Jin L., Zhang P.-W., et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nat. Cell Biol. 2012;487:443&#x2013;448. doi: 10.1038/nature11314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11314</ArticleId><ArticleId IdType="pmc">PMC3408792</ArticleId><ArticleId IdType="pubmed">22801498</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdier J.-M., Acquatella I., Lautier C., Devau G., Trouche S., Lasbleiz C., Mestre-Franc&#xe9;s N. Lessons from the analysis of nonhuman primates for understanding human aging and neurodegenerative diseases. Front. Neurosci. 2015;9:64. doi: 10.3389/fnins.2015.00064.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2015.00064</ArticleId><ArticleId IdType="pmc">PMC4349082</ArticleId><ArticleId IdType="pubmed">25788873</ArticleId></ArticleIdList></Reference><Reference><Citation>Herculano-Houzel S., Mota B., Wong P., Kaas J.H. Connectivity-driven white matter scaling and folding in primate cerebral cortex. Proc. Natl. Acad. Sci. USA. 2010;107:19008&#x2013;19013. doi: 10.1073/pnas.1012590107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1012590107</ArticleId><ArticleId IdType="pmc">PMC2973896</ArticleId><ArticleId IdType="pubmed">20956290</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansfield K. Marmoset models commonly used in biomedical research. Comp. Med. 2003;53:383&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pubmed">14524414</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki E., Suemizu H., Shimada A., Hanazawa K., Oiwa R., Kamioka M., Tomioka I., Sotomaru Y., Hirakawa R., Eto T., et al. Generation of transgenic non-human primates with germline transmission. Nature. 2009;459:523&#x2013;527. doi: 10.1038/nature08090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08090</ArticleId><ArticleId IdType="pubmed">19478777</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller C.T., Freiwald W.A., Leopold D.A., Mitchell J.F., Silva A.C., Wang X. Marmosets: A Neuroscientific Model of Human Social Behavior. Neuron. 2016;90:219&#x2013;233. doi: 10.1016/j.neuron.2016.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.03.018</ArticleId><ArticleId IdType="pmc">PMC4840471</ArticleId><ArticleId IdType="pubmed">27100195</ArticleId></ArticleIdList></Reference><Reference><Citation>Borel F., Gernoux G., Cardozo B., Metterville J.P., Cabrera G.T., Song L., Su Q., Gao G.P., Elmallah M.K., Brown R.H., et al. Therapeutic rAAVrh10 Mediated SOD1 Silencing in Adult SOD1G93A Mice and Nonhuman Primates. Hum. Gene Ther. 2016;27:19&#x2013;31. doi: 10.1089/hum.2015.122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2015.122</ArticleId><ArticleId IdType="pmc">PMC4741242</ArticleId><ArticleId IdType="pubmed">26710998</ArticleId></ArticleIdList></Reference><Reference><Citation>Borel F., Gernoux G., Sun H., Stock R., Blackwood M., Brown R.H., Jr., Mueller C. Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques. Sci. Transl. Med. 2018;10:eaau6414. doi: 10.1126/scitranslmed.aau6414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aau6414</ArticleId><ArticleId IdType="pubmed">30381409</ArticleId></ArticleIdList></Reference><Reference><Citation>Endo K., Ishigaki S., Masamizu Y., Fujioka Y., Watakabe A., Yamamori T., Hatanaka N., Nambu A., Okado H., Katsuno M., et al. Silencing of FUS in the common marmoset (Callithrix jacchus) brain via stereotaxic injection of an adeno-associated virus encoding shRNA. Neurosci. Res. 2018;130:56&#x2013;64. doi: 10.1016/j.neures.2017.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2017.08.006</ArticleId><ArticleId IdType="pubmed">28842245</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida A., Sasaguri H., Kimura N., Tajiri M., Ohkubo T., Ono F., Sakaue F., Kanai K., Hirai T., Sano T., et al. Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43. Brain. 2012;135:833&#x2013;846. doi: 10.1093/brain/awr348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr348</ArticleId><ArticleId IdType="pmc">PMC3286326</ArticleId><ArticleId IdType="pubmed">22252998</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>